Standardization of LC-MS for therapeutic drug monitoring of tacrolimus

Clinical Chemistry

Volumn 59, Issue 11, 2013, Pages 1630-1637

  Annesley, Thomas M ^a   Mckeown, Denise A ^b   Holt, David W ^b   Mussell, Christopher ^c   Champarnaud, Elodie ^c   Harter, Leonie ^d   Calton, Lisa J ^d   Mason, Donald S ^d  

^a UNIVERSITY OF MICHIGAN   (United States)

^b ST GEORGE'S UNIVERSITY OF LONDON   (United Kingdom)

^c LGC   (United Kingdom)

^d WATERS CORPORATION   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

TACROLIMUS;

ARTICLE; CHROMATOGRAPHY; DIAGNOSTIC KIT; DRUG MONITORING; HUMAN; LABORATORY; LIMIT OF QUANTITATION; LIQUID CHROMATOGRAPHY; LIQUID CHROMATOGRAPHY TANDEM MASS SPECTROMETRY; MASS SPECTROMETER; MASS SPECTROMETRY; MEASUREMENT; STANDARDIZATION;

CHROMATOGRAPHY, LIQUID; DRUG MONITORING; HUMANS; IMMUNOSUPPRESSIVE AGENTS; LABORATORY PROFICIENCY TESTING; REFERENCE STANDARDS; TACROLIMUS; TANDEM MASS SPECTROMETRY;

EID: 84887031101     PISSN: 00099147     EISSN: 15308561     Source Type: Journal    
DOI: 10.1373/clinchem.2013.209114     Document Type: Article

References (24)

1. Wallemacq P, Armstrong VW, Brunet M, Haufroid V, Holt DW, Johnson A, et al. Opportunities to optimize tacrolimus therapy in solid organ transplantation: report of the European consensus conference. Ther Drug Monit 2009;31:139- 52.
2. Bouamar R, Shuker N, Hesselink DA, Weimar W, Ekberg H, Kaplan B, et al. Tacrolimus predose concentrations do not predict the risk of acute rejection after renal transplantation: A pooled analysis from three randomized-controlled clinical trials. Am J Transplant 2013;13:1253- 61.
3. Tacrolimus international proficiency testing scheme. http://www. bioanalytics.co.uk/Tacrolimus%20Front%20Pages/tacro206.pdf (Accessed March 2013).
4. Levine DM, Maine GT, Armbruster DA, Mussell C, Buchholz C, O'Connor G, et al. The need for standardization of tacrolimus assays. Clin Chem 2011;57:1739-47.
5. Napoli KL, Hammett-Stabler C, Taylor PJ, Lowe W, Franklin ME, Morris MR, Cooper DP. Multicenter evaluation of a commercial kit for tacrolimus determination by LC/MS/MS. Clin Biochem 2010;43:910 -20.
6. Tempestilli M, Di Stasio E, Rosaria Basile M, Elisei F, Antonini M, Maria Ettorre G, et al. Low plasma concentrations of albumin influence the affinity column-mediated immunoassay method for the measurement of tacrolimus in blood during the early period after liver transplantation. Ther Drug Monit 2013;35:96 -100.
7. Bureau International des Poids et Mesures. JCTLM database: laboratory medicine and in vitro diagnostics. http://www.bipm.org/jctlm/viewResults.do? type-isRM&searchString-tacrolimus&searchStringIUPAC-& searchStringMixed-&analyteCategory-&matrixCategory-&sortBy-Analyte- Name&status-P&id-C9RM21&x-32&y-10 (Accessed April 2013).
8. Barwick V. Evaluating measurement uncertainty in clinical chemistry: LGC/R/2010/17. http://www.nmschembio.org.uk/dm-documents/Clinical-worked- examples-report-Final-f26JC.pdf (Accessed April 2013).
9. Barau C, Frangie C, Goujard C, Tribut O, Parant F, Taburet A, et al. Falsely elevated whole blood tacrolimus concentrations due to interference in an affinity column-mediated immunoassay method on Xpand Dimension. Ther Drug Monit 2009;31: 267-8.
10. Moes DJ, Press RR, de Fijter JW, Guchelaar HJ, den Hartigh J. Liquid chromatography-tandem mass spectrometry outperforms fluorescence polarization immunoassay in monitoring everolimus therapy in renal transplantation. Ther Drug Monit 2010;32:413-9.
11. Laha TJ, Strathmann FG, Wang Z, de Boer IH, Thummel KE, Hoofnagle AN. Characterizing antibody cross-reactivity for immunoaffinity purification of analytes prior to multiplexed liquid chromatography-tandem mass spectrometry. Clin Chem 2012;58:1711- 6.
12. Sadilkova K, Busby B, Dickerson JA, Rutledge JC, Jack RM. Clinical validation and implementation of a multiplexed immunosuppressant assay in dried blood spots by LC-MS/MS. Clin Chim Acta 2013;421:152- 6.
13. Staatz CE, Taylor PJ, Tett SE. Comparison of an ELISA and an LC/MS/MS method for measuring tacrolimus concentrations and making dosage decisions in transplant recipients. Ther Drug Monit 2002;24:607-15.
14. Napoli KL. Is microparticle enzyme-linked immunoassay (MEIA) reliable for use in tacrolimus TDM? Comparison of MEIA to liquid chromatography with mass spectrometric detection using longitudinal trough samples from transplant recipients. Ther Drug Monit 2006;28:491-504. (Pubitemid 44181482)
15. Brown NW, Gonde CE, Adams JE, Tredger JM. Low hematocrit and serum albumin concentrations underlie the overestimation of tacrolimus concentrations by microparticle enzyme immunoassay versus liquid chromatography-tandem mass spectrometry. Clin Chem 2005;51:586 -92. (Pubitemid 40300235)
16. Taylor PJ, Morris RG. Tacrolimus measurement by microparticle enzyme immunoassay II [Editorial]. Ther Drug Monit 2003;25:259-60. (Pubitemid 36638166)
17. Altinier S, Varagnolo M, Zaninotto M, Boccagni P, Plebani M. Heterophilic antibody interference in a non-endogenous molecule assay: An apparent elevation in the tacrolimus concentration. Clin Chim Acta 2009;402:193-5.
18. Taylor PJ, Franklin ME, Tai CH, Pillans PI. Therapeutic drug monitoring of tacrolimus by liquid chromatography-tandem mass spectrometry: is it truly a routine test? J Chromatogr B Analyt Technol Biomed Life Sci 2012;883- 884:108 -112.
19. White GH, Farrance I, AACB Uncertainty of Measurement Working Group. Uncertainty of measurement in quantitative medical testing: A laboratory implementation guide. Clin Biochem Rev 2004;25:S1-24.
20. Moon HW, Cho JH, Hur M, Song J, Oh GY, Park CM, et al. Comparison of four current 25- hydroxyvitamin D assays. Clin Biochem 2012;45: 326-30.
21. Schöttker B, Jansen EHJM, Haug U, Schomburg L, Köhrle J, Brenner H. Standardization of misleading immunoassay based 25-hydroxyvitamin D levels with liquid chromatography tandem-mass spectrometry in a large cohort study. 2012 PLoS ONE 7:e48774.
22. Carter GD, Jones JC. Use of a common standard improves the performance of liquid chromatographytandem mass spectrometry methods for serum 25-hydroxyvitamin-D. Ann Clin Biochem 2009;46: 79-81.
23. Yates AM, Bowron A, Calton L, Heynes J, Field H, Rainbow S, Keevil B. Interlaboratory variation in 25-hydroxyvitamin D2 and 25-hydroxyvitamin D3 is significantly improved if common calibration material is used [Letter]. Clin Chem 2008;54: 2082-4. (Pubitemid 352774049)
24. Percy JA, Chambers AG, Smith DS, Borchers CH. Standardized protocols for quality control of MRM-based plasma proteomic workflows. J Proteome Res 2013;12:222-33.